Multidisciplinary approach for locally advanced non-small cell lung cancer (NSCLC): 2023 expert consensus of the Spanish Lung Cancer Group GECP
Clinical and Translational Oncology · 2024
DOI: 10.1007/s12094-024-03382-y ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical and Translational Oncology, 2024. Verfasst von Aylen Vanessa Ospina und 28 weiteren Autor:innen. Beteiligte Einrichtung: Head of the Oncology Department at the Hospital Universitario Puerta de Hierro. Full Professor of Medicine, Universidad Autónoma de Madrid, C/Manuel …. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Consensus. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 110 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidad Autónoma de Madrid.
Abstract (Originalsprache)
Introduction
Recent advances in the treatment of locally advanced NSCLC have led to changes in the standard of care for this disease. For the selection of the best approach strategy for each patient, it is necessary the homogenization of diagnostic and therapeutic interventions, as well as the promotion of the evaluation of patients by a multidisciplinary oncology team.
Objective
Development of an expert consensus document with suggestions for the approach and treatment of locally advanced NSCLC leaded by Spanish Lung Cancer Group GECP.
Methods
Between March and July 2023, a panel of 28 experts was formed. Using a mixed technique (Delphi/nominal group) under the guidance of a coordinating group, consensus was reached in 4 phases: 1. Literature review and definition of discussion topics 2. First round of voting 3. Communicating the results and second round of voting 4. Definition of conclusions in nominal group meeting. Responses were consolidated using medians and interquartile ranges. The threshold for agreement was defined as 85% of the votes.
Results
New and controversial situations regarding the diagnosis and management of locally advanced NSCLC were analyzed and reconciled based on evidence and clinical experience. Discussion issues included: molecular diagnosis and biomarkers, radiologic and surgical diagnosis, mediastinal staging, role of the multidisciplinary thoracic committee, neoadjuvant treatment indications, evaluation of response to neoadjuvant treatment, postoperative evaluation, and follow-up.
Conclusions
Consensus clinical suggestions were generated on the most relevant scenarios such as diagnosis, staging and treatment of locally advanced lung cancer, which will serve to support decision-making in daily practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Head of the Oncology Department at the Hospital Universitario Puerta de Hierro. Full Professor of Medicine, Universidad Autónoma de Madrid, C/Manuel de Falla, 1 Majadahonda, 28222, Madrid, Spain. avospina@hotmail.com.
- H. General Universitario Dr. Balmis de Alicante, Alicante, Spain.
- Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain.
- H. Clínico San Carlos, Madrid, Spain.
- H. Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.
- H. Universitario Dr Balmis Alicante, Alicante, Spain.
Förderung
- Universidad Autónoma de Madrid
Zitieren
APA
Ospina, A. V., Bolufer Nadal, S., Campo-Cañaveral de la Cruz, J. L., González Larriba, J. L., Macía Vidueira, I., Massutí Sureda, B., Nadal, E., Trancho, F. H., Álvarez Kindelán, A., Del Barco Morillo, E., Bernabé Caro, R., Bosch Barrera, J., Calvo de Juan, V., Casal Rubio, J., de Castro, J., Cilleruelo Ramos, Á., Cobo Dols, M., Dómine Gómez, M., Figueroa Almánzar, S., …, & Provencio, M. (2024). Multidisciplinary approach for locally advanced non-small cell lung cancer (NSCLC): 2023 expert consensus of the Spanish Lung Cancer Group GECP. Clinical and Translational Oncology. https://doi.org/10.1007/s12094-024-03382-y
Vancouver
Ospina AV, Bolufer Nadal S, Campo-Cañaveral de la Cruz JL, González Larriba JL, Macía Vidueira I, Massutí Sureda B, et al. Multidisciplinary approach for locally advanced non-small cell lung cancer (NSCLC): 2023 expert consensus of the Spanish Lung Cancer Group GECP. Clinical and Translational Oncology. 2024. doi:10.1007/s12094-024-03382-y
BibTeX
@article{Ospina2024,
author = {Ospina, Aylen Vanessa and Bolufer Nadal, Sergio and Campo-Cañaveral de la Cruz, José Luis and González Larriba, Jose Luis and Macía Vidueira, Ivan and Massutí Sureda, Bartomeu and Nadal, Ernest and Trancho, Florentino Hernando and Álvarez Kindelán, Antonio and Del Barco Morillo, Edel and Bernabé Caro, Reyes and Bosch Barrera, Joaquim and Calvo de Juan, Virginia and Casal Rubio, Joaquin and de Castro, Javier and Cilleruelo Ramos, Ángel and Cobo Dols, Manuel and Dómine Gómez, Manuel and Figueroa Almánzar, Santiago and Garcia Campelo, Rosario and Insa Mollá, Amelia and Jarabo Sarceda, José Ramón and Jiménez Maestre, Unai and López Castro, Rafael and Majem, Margarita and Martinez-Marti, Alex and Martínez Téllez, Elisabeth and Sánchez Lorente, David and Provencio, Mariano},
title = {Multidisciplinary approach for locally advanced non-small cell lung cancer (NSCLC): 2023 expert consensus of the Spanish Lung Cancer Group GECP},
journal = {Clinical and Translational Oncology},
year = {2024},
doi = {10.1007/s12094-024-03382-y}
}
EUVIMED